ArticleFrontiers in immunology2026
A CDK4/6 inhibitor-armed oncolytic adenovirus reverses T cell exhaustion through the Rb-p65-CCL5 pathway and potentiates the antitumor activity of anti-PD-1 or CAR-T therapy in colorectal cancer.
Dan Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.